Cargando…
Murine CAR19 Tregs suppress acute graft-versus-host disease and maintain graft-versus-tumor responses
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) efficacy is complicated by graft-versus-host disease (GVHD), a leading cause of morbidity and mortality. Regulatory T cells (Tregs) have shown efficacy in preventing GVHD. However, high Treg doses are often required, necessitating substa...
Autores principales: | Bolivar-Wagers, Sara, Loschi, Michael L., Jin, Sujeong, Thangavelu, Govindarajan, Larson, Jemma H., McDonald-Hyman, Cameron S., Aguilar, Ethan G., Saha, Asim, Koehn, Brent H., Hefazi, Mehrdad, Osborn, Mark J., Jensen, Michael C., Wagner, John E., Pennell, Christopher A., Blazar, Bruce R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536261/ https://www.ncbi.nlm.nih.gov/pubmed/35917188 http://dx.doi.org/10.1172/jci.insight.160674 |
Ejemplares similares
-
Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges
por: Hefazi, Mehrdad, et al.
Publicado: (2021) -
Cytolytic CD4(+) and CD8(+) Regulatory T-Cells and Implications for Developing Immunotherapies to Combat Graft-Versus-Host Disease
por: Bolivar-Wagers, Sara, et al.
Publicado: (2022) -
Emerging translational strategies and challenges for enhancing regulatory T cell therapy for graft-versus-host disease
por: Hippen, Keli L., et al.
Publicado: (2022) -
Effects of MicroRNA on Regulatory T Cells and Implications for Adoptive Cellular Therapy to Ameliorate Graft-versus-Host Disease
por: Hippen, Keli L., et al.
Publicado: (2018) -
Achievement of Tolerance Induction to Prevent Acute Graft-vs.-Host Disease
por: Thangavelu, Govindarajan, et al.
Publicado: (2019)